BATS | ETF
The fund is an actively-managed exchange-traded fund (ETF) that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution (Genomics Revolution Companies).
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| TEM | Tempus AI, Inc. Class A Common Stock | Healthcare | Health Information Services | 11.87% |
| CRSP | Crispr Therapeutics AG | Healthcare | Biotechnology | 9.46% |
| TWST | Twist Bioscience Corp | Healthcare | Diagnostics & Research | 5.83% |
| RXRX | Recursion Pharmaceuticals Inc | Healthcare | Biotechnology | 5.33% |
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 4.73% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 4.46% |
| TXG | 10X Genomics Inc | Healthcare | Health Information Services | 4.35% |
| ADPT | Adaptive Biotechnologies Corp | Healthcare | Biotechnology | 3.97% |
| PSNL | Personalis Inc | Healthcare | Diagnostics & Research | 3.68% |
| SDGR | Schrodinger Inc | Healthcare | Health Information Services | 3.67% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 3.51% |
| VCYT | Veracyte Inc | Healthcare | Diagnostics & Research | 3.40% |
| BEAM | Beam Therapeutics Inc | Healthcare | Biotechnology | 3.20% |
| ARCT | Arcturus Therapeutics Holdings Inc | Healthcare | Biotechnology | 2.93% |
| ABSI | Absci Corp | Healthcare | Biotechnology | 2.89% |
| NTLA | Intellia Therapeutics Inc | Healthcare | Biotechnology | 2.87% |
| CDNA | CareDx Inc | Healthcare | Diagnostics & Research | 2.70% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 2.59% |
| PRME | Prime Medicine, Inc. Common Stock | Healthcare | Biotechnology | 1.54% |
| NRIX | Nurix Therapeutics Inc | Healthcare | Biotechnology | 1.47% |